Life science venture firm 5AM Ventures has raised $285 million for fund number 5, according to data from a Form D filing with the U.S. Securities and Exchange Commission. The firm makes investments in life science startups at the seed and early stage of their development.
The investment firm did not immediately return calls for comment.
5 AM Ventures previously raised $250 million in 2013 for 5 AM Ventures IV. It led financing rounds in 11 companies since then, according to data from CrunchBase, such as scPharmaceuticals, Chrono Therapeutics, Cidara Therapeutics, Precision NanoSystem, Biodesy and Pear Therapeutics.
